References
Barkhof F, Filippi M, Miller DH, et al. (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120:2059–2069
Barkhof F, Rocca M, Francis G, et al. (2003) Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon β 1a. Ann Neurol 53:718–724
Brex PA, Miszkiel KA, O’Riordan JI, Plant GT, Moseley IF, Thompson AJ Miller DH (2001) Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: the role of a follow up MRI. J Neurol Neurosurg Psychiatry 70:390–393
Champs study group (2002) MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group. Neurology 59:998–1005
Comi G, Filippi M, Barkhof F, et al. (2001) Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomized study. Lancet 357:1576–1582
Martínez-Yélamos A, Saiz A, Sanchez-Valle R, et al. (2001) 14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis. Neurology 57:722–724
McDonald WI, Compston A, Edan G, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127
Poser CM, Paty DW, Scheinberg L, et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231
Scott TF, Schramke CJ, Novero J, Chieffe C (2000) Short-term prognosis in early relapsing-remitting multiple sclerosis. Neurology 55:689–693
Weinshenker BG, Rice GPA, Noseworthy J, Carriere W, Baskerville J, Ebers GC (1991) The natural history of multiple sclerosis: a geographically based study: 3.Multivariate analysis of predictive factors and models of outcome. Brain 114:1045–1056
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martínez-Yélamos, A., Rovira, A., Sánchez-Valle, R. et al. CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS. J Neurol 251, 1278–1279 (2004). https://doi.org/10.1007/s00415-004-0524-y
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00415-004-0524-y